Clinical features of paediatric pulmonary hypertension: a registry study

Simonneau, 2009, Updated clinical classification of pulmonary hypertension, J Am Coll Cardiol, 54, S43, 10.1016/j.jacc.2009.04.012 D'Alonzo, 1991, Survival in patients with primary pulmonary hypertension. Results from a national prospective registry, Ann Intern Med, 115, 343, 10.7326/0003-4819-115-5-343 Humbert, 2006, Pulmonary arterial hypertension in France: results from a national registry, Am J Respir Crit Care Med, 173, 1023, 10.1164/rccm.200510-1668OC Frost, 2011, The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US contemporary registries, Chest, 139, 128, 10.1378/chest.10-0075 Galiè, 2009, Eur Heart J, 30, 2493, 10.1093/eurheartj/ehp297 McLaughlin, 2009, J Am Coll Cardiol, 53, 1573, 10.1016/j.jacc.2009.01.004 Barst, 2011, Pulmonary arterial hypertension: a comparison between children and adults, Eur Respir J, 37, 665, 10.1183/09031936.00056110 Berger, 2010, Treatment options in pediatric pulmonary arterial hypertension, Eur Respir Rev, 19, 321, 10.1183/09059180.00008410 van Loon, 2009, Clinical characterization of pediatric pulmonary hypertension: complex presentation and diagnosis, J Pediatr, 155, 176, 10.1016/j.jpeds.2009.02.036 Simonneau, 2004, Clinical classification of pulmonary hypertension, J Am Coll Cardiol, 43, S5, 10.1016/j.jacc.2004.02.037 van Loon, 2011, Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005, Circulation, 124, 1755, 10.1161/CIRCULATIONAHA.110.969584 Galiè, 2006, Bosentan randomized trial of endothelin antagonist therapy-5 (BREATHE-5) investigators. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study, Circulation, 114, 48, 10.1161/CIRCULATIONAHA.106.630715 Singh, 2006, A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension, Am Heart J, 151, 851.e1, 10.1016/j.ahj.2005.09.006 van Loon, 2007, Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?, Am Heart J, 154, 776, 10.1016/j.ahj.2007.06.003 Haworth, 2009, Treatment and survival in children with pulmonary arterial hypertension: the UK pulmonary hypertension service for children 2001–2006, Heart, 95, 312, 10.1136/hrt.2008.150086 Badesch, 2010, Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry, Chest, 137, 376, 10.1378/chest.09-1140 Stenmark, 2005, Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia, Annu Rev Physiol, 67, 623, 10.1146/annurev.physiol.67.040403.102229 Khemani, 2007, Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era, Pediatrics, 120, 1260, 10.1542/peds.2007-0971 Jobe, 2011, The new bronchopulmonary dysplasia, Curr Opin Pediatr, 23, 167, 10.1097/MOP.0b013e3283423e6b Kessler, 2001, Natural history of pulmonary hypertension in a series of 131 patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 164, 219, 10.1164/ajrccm.164.2.2006129 Chi, 1975, The pulmonary vascular bed in children with Down syndrome, J Pediatr, 86, 533, 10.1016/S0022-3476(75)80142-9 McDowell, 2011, Pulmonary complications of Down syndrome during childhood, J Pediatr, 158, 319, 10.1016/j.jpeds.2010.07.023 Marcus, 1991, Obstructive sleep apnea in children with Down syndrome, Pediatrics, 88, 132, 10.1542/peds.88.1.132 Cooney, 1982, Pulmonary hypoplasia in Down syndrome, N Engl J Med, 307, 1170, 10.1056/NEJM198211043071902 Pfizer Le, 2011, Syncope in adults with pulmonary arterial hypertension, J Am Coll Cardiol, 58, 863, 10.1016/j.jacc.2011.04.026 Rosenzweig, 2008, Pulmonary arterial hypertension in children: a medical update, Curr Opin Pediatr, 20, 288, 10.1097/MOP.0b013e3282ff5fdc